Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PhageLab logo — A biotech company creating tailor-made solutions to global b...

PhageLab

A biotech company creating tailor-made solutions to global bacterial challenges. Science works and we can prove it.

Founded 2010 Chile Chile 95 employees Series A Total: $11.04M Biotechnology, Enterprise Software +1

General Information

Company Name PhageLab
Founded Year 2010
Location Chile Chile
Employees 95
Industries Biotechnology, Enterprise Software, Pharmaceutical
Funding Stage Series A
Business Model B2B, B2B2C, Platform
Revenue Model Service Fee, Product Sales, Licensing
Social

BounceWatch is an independent company data service, not affiliated with PhageLab. To contact PhageLab, visit phage-lab.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PhageLab compare?

A PDF of PhageLab and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PhageLab soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PhageLab

PhageLab is a pioneering biotech firm dedicated to developing custom antibacterial solutions tailored to global bacterial challenges. Founded in 2010, the company leverages a robust AI-powered protocol to diagnose and eliminate specific bacterial pathogens effectively, ensuring farm health globally. With more than 14 years of experience, PhageLab partners extensively with poultry and livestock producers, providing fast and precise diagnostics.

Headquartered in Chile, PhageLab stands on the cutting edge of biotechnology and is committed to the One Health principle. With a prominent bacteriophage repository and exceptional data-gathering capabilities, the company leads the intersection of science and technology. Recently, PhageLab secured a $11.00M Series A investment on January 23, 2024, backed by notable investors including Collaborative Fund, WaterLemon Ventures, Nazca Ventures, and Kevin Efrusy. The company's vision is succinctly captured in its slogan: "Science works and we can prove it."

Business keywords: Biotechnology Solutions, Bacteriophage Therapy, Poultry Sector, Livestock Health, Antibacterial Development, AI-Powered Diagnosis, Pathogen Elimination, One Health Initiative, Data-Driven Biotech, Global Biotech Company, Veterinary Solutions, Custom Biotech Solutions, Streamlined Protocols, Biotechnological Innovation, Industrial Biotechnology

Services & Products

Bacteriophage-based solutions
AI-driven pathogen elimination
Non-invasive diagnostic protocols
Laboratory analysis and phage application

Target Customers

Livestock producers Poultry producers Animal health companies Food production industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $11.00M 4
Collaborative Fund WaterLemon Ventures
Collaborative Fund, WaterLemon Ventures +2
23 Jan 2024
Seed Round $40.00K 1
Start-Up Chile
Start-Up Chile
17 Jul 2012

PhageLab Alternatives & Competitors

PhageLab vs
Provolut
Provolut Germany

Redefining Protein Design: Driven by Artificial Intelligence. Guided by Human Ingenuity.

Seed
8 employees
Biotechnology, Pharmaceutical
Compare PhageLab vs Provolut

FAQ About PhageLab

A biotech company creating tailor-made solutions to global bacterial challenges. Science works and we can prove it.
PhageLab was founded in 2010.
PhageLab is headquartered in Chile.
PhageLab operates in Biotechnology, Enterprise Software and Pharmaceutical. Its work centres on Biotechnology Solutions, Bacteriophage Therapy, Poultry Sector and Livestock Health. Its customers include Livestock producers, Poultry producers and Animal health companies.
PhageLab has a B2B, B2B2C and Platform business model. Its revenue comes from Service Fee, Product Sales and Licensing.
PhageLab has approximately 95 employees.
PhageLab has completed 2 funding rounds, raising a total of $11.04M. The latest funding stage is Series A.
PhageLab offers: Bacteriophage-based solutions, AI-driven pathogen elimination, Non-invasive diagnostic protocols, Laboratory analysis and phage application.
Top alternatives and competitors to PhageLab include Provolut. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PhageLab and Provolut are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PhageLab, https://bouncewatch.com/company/phagelab, updated 15 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout